Rohit Jain, MD
Weill Cornell Medicine/New York-Presbyterian Hospital
Topic Presenter
Biography
Rohit K. Jain, MD, MPH is an Associate Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine and NewYork-Presbyterian Hospital. He is a medical oncologist and clinical researcher who specializes in bladder, kidney, and prostate cancers. His research focuses on bladder cancer, especially antibody-drug conjugates, FGFR-targeted therapies, and immunotherapy combinations. He leads clinical trials that bring new treatment combinations to patients.
Financial Disclosure
EMD Serono, Bristol Myers Squibb, Merck, Seattle Genetics, Astellas, Janssen, Pfizer, Gilead, Eli Lilly, Exelixis, Sanofi, Novartis, and AstraZeneca; honoraria from Dava Oncology, Curio Science, Axiom, MJH, Ideo-Oncology, and FLASCO
Consultant
Eli Lilly
Advisor
research support from Bristol Myers Squibb, Gilead, and NCI/CTEP
Grant Or Contract